688809-97-4

Usage

Uses

Used in Pharmaceutical Industry:
3-(Methoxymethyl)piperidine hydrochloride is used as a key building block for the synthesis of various drugs due to its unique chemical structure and properties.
Used in the Production of Antipsychotic Medications:
3-(Methoxymethyl)piperidine hydrochloride is used as an intermediate in the synthesis of antipsychotic drugs, contributing to the development of medications that help manage psychotic disorders.
Used in the Production of Sedative Medications:
3-(METHOXYMETHYL)PIPERIDINE HYDROCHLORIDE is utilized as an intermediate in the creation of sedative medications, aiding in the formulation of drugs that promote relaxation and sleep.
Used in the Production of Analgesic Medications:
3-(Methoxymethyl)piperidine hydrochloride is employed as an intermediate in the synthesis of analgesic drugs, which are essential for the management of pain.
Used in the Development of Novel Therapeutic Agents:
3-(METHOXYMETHYL)PIPERIDINE HYDROCHLORIDE has potential applications in the development of new therapeutic agents, indicating its versatility and importance in advancing pharmaceutical research and innovation.
Used in Research Studies:
3-(Methoxymethyl)piperidine hydrochloride is used in research studies to explore its properties and potential applications, furthering the understanding of its role in drug development and therapeutic interventions.

Upstream product

• 162166-99-6 3-methanesulfonyloxymethyl-piperidine-1-carboxylic acid tert-butyl ester 
• 148763-41-1 1-(tert-butyl) 3-methyl piperidine-1,3-dicarboxylate 
• 116574-71-1 (±)-tert-butyl 3-(hydroxymethyl)piperidine-1-carboxylate 
• 868065-26-3 t-butyl 3-(methoxymethyl)piperidine-1-carboxylate 

Downstream Products

• 1351089-27-4 N-methyl-4-{3-[(methyloxy)methyl]-1-piperidinyl}-3-(1H-purin-6-ylamino)benzenesulfonamide 
• 1268867-14-6 methyl 2-(4-fluorophenyl)-3-(3-(methoxymethyl)piperidin-1-yl)quinoxaline-6-carboxylate 

Relevant academic research and scientific papers

NOVEL COMPOUNDS AS INHIBITORS OF RENIN

The present invention relates to novel renin inhibitors of general formula (1), novel intermediates involved in their synthesis, their pharmaceutically acceptable salts and pharmaceutical compositions containing them. The present invention also relates to

2-SUBSTITUTED-ETHYNYLTHIAZOLE DERIVATIVES AND USES OF SAME

The present invention provides 2-substituted-ethynylthiazole derivatives of formula (I): wherein R1, R2 and X are as defined herein, or a pharmaceutically acceptable salt thereof; and pharmaceutical compositions and methods of using same.

NOVEL COMPOUNDS AS INHIBITORS OF RENIN

The present invention relates to novel renin inhibitors of general formula (1), novel intermediates involved in their synthesis, their pharmaceutically acceptable salts and pharmaceutical compositions containing them. The present invention also relates to

RENIN INHIBITORS

The present invention relates to novel renin inhibitors of general formula (1), novel intermediates involved in their synthesis, their pharmaceutically acceptable salts and pharmaceutical compositions containing them. The present invention also relates to a process of preparing compounds of general formula (1), their tautomeric forms, their pharmaceutically acceptable salts, pharmaceutical compositions containing them, and novel intermediates involved in their synthesis.

Novel Compounds

Compounds of Formulae I, or pharmaceutically acceptable salts thereof: wherein X, R1, R2 and R3 are as defined in the specification as well as salts and pharmaceutical compositions including the compounds are prepared. They are useful in therapy, in particular in the management of pain.

NOVEL QUINOXALINE DERIVATIVES

A quinoxalinone derivative of the formula (I): or a pharmaceutically acceptable salt or ester thereof, wherein; ???X is NH, S or the like; ???Y is O or the like; ???the partial structure is, for example, the formula: ???B1, B2, ....., Bn-1 and Bn, (in which n is 4 , 5 or 6) are each independently CH, N or the like; ???B'1, B'2, ....., B'n-1 and B'n (in which n is 4, 5 or 6) are each independently hydrogen or the like; and ???R is hydrogen, lower alkyl or the like.